Abstract
Free full text
Regulation of the X Chromosomes in Caenorhabditis elegans
Abstract
Dosage compensation, which regulates the expression of genes residing on the sex chromosomes, has provided valuable insights into chromatin-based mechanisms of gene regulation. The nematode Caenorhabditis elegans has adopted various strategies to down-regulate and even nearly silence the X chromosomes. This article discusses the different chromatin-based strategies used in somatic tissues and in the germline to modulate gene expression from the C. elegans X chromosomes and compares these strategies to those used by other organisms to cope with similar X-chromosome dosage differences.
OVERVIEW
Dosage compensation, which regulates the expression of genes residing on the sex chromosomes, has provided valuable insights into epigenetic mechanisms used to regulate whole chromosomes. The nematode Caenorhabditis elegans has adopted various strategies to down-regulate and even silence the X chromosomes. This article discusses the different chromatin-based strategies used in somatic tissues and in the germline to modulate gene expression from the C. elegans X chromosomes, and compares these strategies to those used by other organisms to cope with similar X-chromosome dosage differences.
Why is dosage compensation necessary? The mechanism of sex determination in C. elegans relies on the ratio of X chromosomes to sets of autosomes (X:A ratio). Diploid animals with two X chromosomes (X:A ratio of 1) develop as hermaphrodites, whereas those with one X chromosome (X:A ratio of 0.5) develop as males. The difference in X-chromosome dosage between the sexes, if not rectified, leads to imbalanced expression of X-linked genes and to lethality in one sex. Thus, equalizing expression of X-linked genes between the sexes is one function of dosage compensation.
In the somatic tissues of worms, dosage compensation occurs by down-regulating transcription approximately twofold from each of the two X chromosomes in the XX sex. This down-regulation is accomplished by the dosage compensation complex (DCC), a constellation of proteins assembled specifically on the X chromosomes of XX animals. The protein components of the DCC are homologous to members of the condensin complex, which is required for chromosome condensation and segregation during mitosis and meiosis. The similarity between the DCC and condensin complexes has led to the hypothesis that the DCC achieves repression of X-linked genes by partially condensing the X chromosomes. Long-standing questions surrounding dosage compensation in C. elegans include how the X:A ratio is assessed, how the DCC is assembled uniquely in XX animals, how the DCC is targeted to the X chromosomes, and the mechanism by which it accomplishes twofold down-regulation of X-linked gene expression. This article summarizes the substantial progress that has been made in answering these key questions.
The dosage compensation strategy used by C. elegans differs from the strategies used by mammals and fruit flies (Drosophila). Mammals achieve dosage compensation by globally silencing one X in the female (XX) sex. Fruit flies up-regulate gene expression from the single X in the male (XY) sex. This diversity of strategies probably reflects the co-option of different preexisting general chromatin mechanisms for the specialized role of equalizing X gene expression between sexes.
In addition to mechanisms that equalize gene dosage between sexes, there is strong evidence that these organisms also correct the chromosome dosage imbalance within cells, which is caused by a single dose of X-linked expression versus biallelic autosomal expression. In C. elegans and mammals, this is achieved by up-regulation of expressed X-linked genes in both sexes. Thus, in C. elegans hermaphrodites and mammalian females, down-regulation of the X via dosage compensation mechanisms is superimposed on this general up-regulation.
In the germline tissue (i.e., the reproductive cells) of worms, a more extreme modulation of X-linked gene expression occurs. Transcription from the single X in males and both Xs in hermaphrodites is significantly repressed in proliferating and meiotic germ cells. In germ cells of both sexes, the X chromosomes lack histone modifications that are associated with actively expressed chromatin. This is regulated at least in part by the MES proteins, chromatin modifiers whose loss leads to sterility. Furthermore, in males, the single X chromosome in each germ nucleus acquires histone modifications that are associated with heterochromatic silencing. This silencing depends on the unpaired status of the X in male meiosis. Genes expressed in the germline are strikingly underrepresented on the X chromosome. A favored view is that heterochromatinization of the unpaired X in male meiotic germ cells led to selection against X linkage of genes required for essential germline functions. In addition, the equalization of X-linked gene expression between the sexes may also be required in germ cells, and the most straightforward way to achieve this may have been to repress both X chromosomes in the XX sex. Thus, the C. elegans germline continues to be a critical system to explore how chromosome imbalances between the sexes have led to epigenetic regulation of chromosome states and gene expression.
1. SEX CHROMOSOME IMBALANCE IN C. elegans
C. elegans exists as two sexes that are genetically distinguished by their X-chromosome complement. XX worms are hermaphrodites and XO worms are males. There is no sex-specific chromosome, such as a Y chromosome. Hermaphrodites and males display numerous sex-specific anatomical features and have different germline developmental programs (Fig. 1). These dramatic differences between the sexes are initiated in the early embryo, and result from counting and properly responding to the number of X chromosomes relative to autosomes (Nigon 1951; reviewed in Meyer 2000). How can a simple difference in sex chromosome number translate into such dramatically different developmental programs? An important concept is that C. elegans cells must assess not only the number of X chromosomes but also the number of sets of autosomes. It is the ratio of these—the X:A ratio—that determines sex. Diploid animals with two X chromosomes (X:A ratio of 1) develop as hermaphrodites, whereas those with one X chromosome (X:A ratio of 0.5) develop as males (Fig. 2). Many of the mechanistic details of appropriately responding to the X:A ratio have been elegantly dissected and are summarized in Sections 3–5.
The difference in X-chromosome dosage between the sexes leads, if uncorrected, to a difference in the levels of X-linked gene expression. Indeed, the double dose of X genes is lethal to hermaphrodites if not corrected. Intriguingly, somatic cells and germ cells have evolved different mechanisms to deal with this X-dosage challenge (Fig. 3). The germline and somatic lineages are fully separated from each other by the 24-cell stage of embryogenesis. Starting at about the 30-cell stage, the somatic lineages initiate a process termed “dosage compensation” whereby genes that reside on the X chromosomes of XX animals are down-regulated approximately twofold. In contrast, as discussed in Brockdorff and Turner (2014) and Kuroda and Lucchesi (2014), mammals implement dosage compensation by globally silencing one X in the XX sex, and fruit flies implement dosage compensation by up-regulating expression from the single X in the XY sex. In C. elegans germline tissue, a more extreme adjustment of X-linked gene expression occurs: The single X in males and both Xs in hermaphrodites are globally repressed. The chromatin-based mechanisms that accomplish dosage compensation in the soma and X-chromosome repression in the germline are the subjects of this article.
2. ASSESSING THE X:A RATIO
How do worm cells count Xs and autosomes so that dosage compensation is implemented when the X:A ratio is 1? Four small regions of the X, termed X signal elements (XSEs), have been identified as contributing to the numerator portion of the X:A ratio. By mutagenesis, four responsible X-linked genes have been identified within the XSE regions: sex-1 (sex for signal element on X), fox-1 (fox for feminizing gene on X), ceh-39, and sex-2 (Carmi et al. 1998; Skipper et al. 1999; Gladden and Meyer 2007; Gladden et al. 2007). These four genes repress expression of xol-1, the most upstream gene in the sex determination and dosage compensation pathway, during a critical window of embryonic development (Fig. 2). Because XX embryos produce approximately twice as much SEX-1, SEX-2, CEH-39, and FOX-1 as XO embryos, xol-1 expression is much lower in XX than in XO embryos. One of the XSE genes, SEX-1, is a nuclear hormone receptor, which represses transcription of xol-1 (Carmi et al. 1998). FOX-1 is an RNA-binding protein that reduces the level of XOL-1 protein through unknown posttranscriptional mechanisms (Nicoll et al. 1997; Skipper et al. 1999; Gladden et al. 2007). CEH-39 has a predicted DNA-binding domain that is similar to the ONECUT family of homeobox-containing transcription factors. CEH-39 does not contain sequence similarity to ONECUT proteins outside the DNA-binding domain (Gladden and Meyer 2007). Reducing the level of individual XSEs has a small effect on sex determination. Combined reductions have a larger effect, suggesting that the XSEs act cooperatively (Gladden and Meyer 2007). The functional readout of X-chromosome dosage is therefore equivalent to the dosage of X-linked factors expressed from XSEs that act to repress expression of xol-1. Thus far, only one autosomal signal element (ASE) has been identified as contributing to the denominator portion of the X:A ratio (Powell et al. 2005). The identified gene, sea-1, encodes a T-box transcription factor, which activates transcription of xol-1.
Autosomal dosage (ASE dosage) therefore counterbalances X dosage (XSE dosage) effects through antagonistic action on the master regulator switch, xol-1 (Fig. 2). The working hypothesis for how this plays out in both sexes is as follows. Diploid XX embryos produce a double dose of XSE repressors of xol-1, which override the activating influence of ASEs. This keeps XOL-1 levels low and leads to hermaphrodite development and implementation of dosage compensation. Conversely, XO embryos produce a single dose of XSE repressors, which is insufficient to counteract the activating influence of ASEs. High XOL-1 levels lead to male development and failure to implement dosage compensation. In this way, the XSEs and ASEs translate an X:A ratio of either 0.5 or 1 into a switch for sex determination, and for deciding whether or not to implement dosage compensation.
3. THE DOSAGE COMPENSATION COMPLEX (DCC) RESEMBLES THE CONDENSIN COMPLEX
Understanding the assembly and composition of the DCC on the X chromosomes requires a brief introduction to the first few genes in the pathway that regulates both sex determination and dosage compensation (Fig. 2) (reviewed in Meyer 1997). xol-1 (xol for XO-lethal), the first gene in the pathway, is considered a master switch gene because its activity is determined by the X:A ratio and it, in turn, dictates whether the pathway leads to male or hermaphrodite development. XOL-1 is a negative regulator of sdc-2 (sdc for sex determination and dosage compensation defective) gene. The sdc genes, sdc-1, sdc-2, and sdc-3, encode components of the DCC and also regulate the her-1 (her for hermaphroditization of XO animals) sex determination gene. In XO embryos, an X:A ratio of 0.5 leads to high XOL-1 protein levels and low SDC-2 protein levels; the DCC is not assembled, dosage compensation is not implemented, and the sex determination gene her-1 is expressed, leading to male sexual development. In XX embryos, an X:A ratio of 1 results in low XOL-1 and high SDC-2 levels; the DCC is assembled, dosage compensation is implemented, and her-1 is repressed, leading to hermaphrodite sexual development.
In addition to the SDC proteins (SDC-1, SDC-2, and SDC-3), the DCC also contains a set of DPY (DPY for dumpy) proteins (DPY-21, DPY-26, DPY-27, DPY-28, and DPY-30), MIX-1 (MIX for mitosis and X-associated), and the more recently identified CAPG-1 protein (Csankovszki et al. 2009) (see Table 1; reviewed in Meyer 2005). Significant insights into the mechanism of dosage compensation in worms came from the discovery that a portion of the C. elegans DCC resembles the 13S condensin I complex (Table 1 and Fig. 4). The condensin complex is conserved among all eukaryotes and is essential for proper chromosome compaction and segregation during mitosis and meiosis (reviewed in Hirano 2002). The core of the DCC includes DPY-26, DPY-27, DPY-28, MIX-1, and CAPG-1, which are homologous to members of the condensin complex. In fact, in addition to their functions in the DCC, all of the core proteins except DPY-27 function in a true condensin complex with SMC-4 to form the canonical five-subunit condensin I that acts in mitosis and meiosis. The SDC proteins DPY-21 and DPY-30, however, do not resemble known condensin subunits. The current view is that the DCC complex was derived from an ancestral condensin complex for targeted down-regulation of genes on the X chromosome, likely through a mechanism involving some degree of chromatin condensation.
Table 1.
Protein | Complex | Homolog and/or conserved domains |
---|---|---|
SDC-1 | DCC | C2H2 zinc-finger domain |
SDC-2 | DCC | Novel protein |
SDC-3 | DCC | C2H2 zinc-finger domain and myosin-like ATP-binding domain |
DPY-21 | DCC | Conserved protein; no recognizable motifs |
DPY-27 | DCC | Condensin subunit homolog SMC-4/XCAP-C |
DPY-30 | DCC | Subunit of the MLL/COMPASS complex |
DPY-26 | DCC, condensin I | Condensin subunit XCAP-H |
DPY-28 | DCC, condensin I | Condensin subunit XCAP-D2/Cnd1/Ycs4p |
CAPG-1 | DCC, condensin I | Condensin subunit XCAP-G |
MIX-1 | DCC, condensin I, II | Condensin subunit SMC-2/XCAP-E |
MES-2 | MES-2/3/6 | PRC2 subunit E(Z)/EZH2; SET domain |
MES-3 | MES-2/3/6 | Novel protein |
MES-6 | MES-2/3/6 | PRC2 subunit ESC/EED; WD40 domains |
MES-4 | Unknown | NSD proteins; PHD fingers and SET domain |
Why is the DCC assembled only in XX embryos? Surprisingly, most of the DCC components are maternally supplied via the oocyte to both XX and XO embryos. The key regulator of DCC assembly is SDC-2 (Dawes et al. 1999). SDC-2 is not maternally supplied and is produced only in XX embryos (Fig. 2), in which it, along with SDC-3 and DPY-30, recruits the remaining DCC complex subunits to the X chromosomes (Fig. 5). In fact, driving expression of SDC-2 in XO embryos is sufficient to cause assembly of the DCC on the single X chromosome and to trigger dosage compensation, which kills the XO embryos. SDC-2 thus directs the specific recruitment of other DCC components, most of which have other cellular roles, and co-opts their activities for dosage compensation and sex determination.
4. RECRUITMENT AND SPREADING OF THE DCC
Several studies have focused on identifying features of the X chromosome involved in recruiting the DCC. An elegant approach was used to investigate whether the DCC is recruited independently to many sites or just a few sites, after which complexes spread into adjoining chromosomal regions (Lieb et al. 2000; Csankovszki et al. 2004; Meyer 2005). Worm strains containing duplications of different regions of the X chromosome were stained for DCC components. Association of the DCC with a duplication was interpreted to mean that the duplicated region contained a DCC recruitment site. Lack of DCC association with the duplication, but association of DCC with the corresponding region of the intact X, was interpreted to mean that the duplicated X region lacks a DCC recruitment site and instead acquires DCC at its endogenous locus by spreading from adjoining regions. These experiments identified at least 13 regions that can independently recruit the DCC, and provided evidence for DCC spreading along the X (Fig. 5A) (Csankovszki et al. 2004). Some regions recruit strongly and others weakly, suggesting either the presence of varying numbers of recruitment sites or of sites with varying capacity to recruit and/or promote spreading along the X (Csankovszki et al. 2004).
Finer mapping of the X-chromosome regions that are capable of recruiting the DCC identified smaller regions, called rex sites (rex for recruitment elements on the X) (McDonel et al. 2006). To test whether rex recruitment sites have a common DNA sequence, it was necessary to identify many other sites of DCC recruitment to the X. The key technology for these experiments was chromatin immunoprecipitation (ChIP) using two DCC subunits (DPY-27 and SDC-3) coupled to microarray analysis (ChIP-chip). This provided maps of DCC binding sites across the X and resulted in the identification of a 10-bp DNA sequence motif enriched at sites of high DCC binding (Ercan et al. 2007). The 10-bp motif was extended to 12 bp by a combination of ChIP-chip and extrachromosomal recruitment assays (Jans et al. 2009). The 12-bp DNA sequence motif (Fig. 5B) is necessary for recruiting the DCC to rex sites. It is estimated that there are 100–300 rex sites distributed along the ~17 MB X chromosome (Jans et al. 2009). Although enriched on the X and more clustered on the X (Ercan et al. 2007), many copies of the 12-bp DNA sequence motif are present on the autosomes, but do not recruit the DCC. Thus, the motif is important, but not sufficient for DCC recruitment. The DNA or chromatin context of the motif may contribute to DCC recruitment, and clustering may be important for increasing the affinity for recruitment. SDC-2 is the first protein to localize to the X, and it recruits the other DCC members to the X chromosome, but whether it is SDC-2 or another factor that directly recognizes the DNA sequence motif at rex sites is not known. Regardless, it is clear that the initial recruitment of the DCC to the X in XX hermaphrodite embryos has at least two components: the DNA sequence motif at rex sites and the SDC-2 protein. It is interesting to note that in mammals and fruit flies, the dosage compensation machinery is targeted to the X chromosome by a combination of X-specific noncoding RNAs and X-chromosome sequence elements (see Brockdorff and Turner 2014; Kuroda and Lucchesi 2014). There is no evidence to date, however, that noncoding RNAs function in C. elegans dosage compensation.
A critical unanswered question is how DCC spreading occurs from the initial recruitment sites (Fig. 5B). Most of the tested sites on the X chromosome are not able to recruit the DCC by themselves, yet the DCC is bound to them in the context of the natural chromosome. The DCC accumulates through a spreading mechanism, especially at the promoters of actively transcribed genes (Ercan et al. 2007). In experiments using X-to-autosome end-to-end fusion chromosomes, the DCC was also shown to spread from the X to juxtaposed autosomal sequences, indicating that unlike recruitment, DCC spreading is not dependent on any particular property of X-linked DNA sequences (Ercan et al. 2009). Furthermore, DCC spreading onto juxtaposed autosomal DNA is concentrated on the promoter regions of actively transcribed genes, just as it is on the natural X chromosome.
In summary, spreading of the DCC onto active promoters is governed by a mechanism that is not specific to the X chromosome, but DCC spreading is largely restricted to the X via recruitment of the DCC to rex sites (Fig. 5). What property of active promoters does the DCC recognize? One candidate is a histone variant H2A.Z because upon depletion of H2A.Z, DCC immunostaining is no longer as sharply restricted to the X chromosome as in wild type (Petty et al. 2009). Spreading may also be mediated by cooperative interactions between DCC complexes, physical interaction with the transcription machinery, or local modification of chromatin into a structure that facilitates more DCC binding in a self-reinforcing loop as shown for the spread of heterochromatin in Schizosaccharomyces pombe (see Martienssen and Moazed 2014).
5. EFFECTS OF THE DCC: DOWN-REGULATION OF X-LINKED GENES AND THE AUTOSOMAL GENE her-1
Mammals, fruit flies, and worms appear to have co-opted different preexisting chromatin complexes to serve the specialized role of modulating gene expression from the X chromosome. Mammals have used heterochromatin-based silencing to inactivate one of the two Xs in the XX sex. Fruit flies have used chromatin-modifying machinery to alter the state of the single X in XY animals, leading to up-regulation of gene expression. C. elegans has adapted a chromosome condensation mechanism typically used for mitosis and meiosis to down-regulate both Xs in the XX sex. Regulating chromatin structure to achieve modest twofold effects on X-linked gene expression, as occurs in worms and fruit flies, seems mechanistically challenging. The precise mechanism of down-regulation in worms and how down-regulation is limited to approximately twofold are critical questions.
Microarray analysis of RNA levels in XX wild type, XX DCC mutants, and XO embryos that are phenotypically hermaphrodite provided insight into C. elegans X-chromosome dosage compensation (Jans et al. 2009). In XX DCC mutant embryos, ~40% of expressed X-linked genes showed an increase in transcript levels, whereas only 2.5% showed a decrease. This is consistent with the expectation that the DCC represses the X chromosome. However, there was not a uniform twofold effect. The range of change was from 1.5-fold (the lowest ratio allowed for a “significant change”) to 10-fold. Nevertheless, the average effect across X-linked genes whose expression significantly increased in DCC mutants was approximately twofold.
The mechanism by which the DCC achieves an average twofold reduction in transcript levels remains unknown. Microarray experiments revealed a disconnect between DCC binding and transcriptional response upon loss of DCC function. At the gene level, genes that were bound by the DCC were equally likely to be dosage compensated or not. This was interpreted to mean that the DCC does not directly regulate the genes to which it binds, but rather that it regulates “at a distance” (Fig. 6A) (Jans et al. 2009). At the genome level, although the DCC binds primarily to the X chromosome, loss of DCC function causes misexpression of some autosomal genes: repression of ~25% and activation of 7%. Jans et al. hypothesized that the DCC may repel a rate-limiting general transcription factor from the X, and that in the absence of the DCC this factor would be re-distributed on all chromosomes (Fig. 6B) (Jans et al. 2009). An alternative interpretation to explain the disconnect between binding and regulation at both the gene level and genome-wide level is that the DCC does indeed regulate genes directly at its sites of binding, but that steady-state measurements of mRNA levels in XX DCC mutants are dominated by secondary effects, rather than direct transcriptional responses to dosage compensation defects. Even in yeast, in which transcription factors bind very near to the genes they regulate, overlap between genes bound by a transcription factor and genes misregulated in the absence of that factor is often small (Gao et al. 2004; Chua et al. 2006; Hu et al. 2007). The issue of whether the DCC acts locally and/or at a distance is therefore unresolved. A high priority should be to determine whether the mechanism of DCC action is local, affecting genes near where it is bound, or whether the mechanism acts at a distance to affect genes across the entire X.
Histone modifications are often involved in establishing more “active” or “repressed” chromatin regions. In fruit flies, up-regulation of X gene expression in males is associated with H4K16 acetylation (H4K16ac) and loss of linker histone from the X (see Kuroda and Lucchesi 2014). H4K16ac is enriched on the X chromosome by the action of MOF acetyltransferase, a subunit of the fly DCC, reducing compaction of nucleosomes. Its effect on transcription has been shown to be on transcription initiation (Conrad et al. 2012) and elongation (Larschan et al. 2011). To date, no histone modification activity has been attributed to the C. elegans DCC. DPY-30, a component of the DCC, is a noncatalytic structural component of the H3K4 methylating MLL/COMPASS complex (Fig. 5B) (Pferdehirt et al. 2011), but whether DPY-30 regulates H3K4 methylation specifically on the X chromosome has not been tested.
Although the DCC has no known direct histone-modifying activity, there is a newly recognized involvement of the histone modification monomethylated H4K20 (H4K20me1) in dosage compensation. H4K20me1, which is associated with gene repression in other species (Karachentsev et al. 2005; Yang and Mizzen 2009), becomes enriched on the X chromosomes in XX hermaphrodites (Liu et al. 2011). H4K20me1 enrichment is dependent on functional DCC, and accumulation of H4K20me1 occurs after dosage compensation is established (Vielle et al. 2012). Immunofluorescence analysis of H4K20me1 and H4K16ac in wild-type adult somatic nuclei showed that the X chromosomes have higher levels of H4K20me1 and lower levels of H4K16ac compared to the autosomes (Wells et al. 2012). Reducing SET-1 enzyme, which monomethylates H4K20, resulted in increased levels of H4K16ac on the Xs. Reducing the SIR-2.1 enzyme, which is responsible for depletion of H4K16ac on the X, however, did not affect H4K20me1 enrichment on the Xs (Wells et al. 2012). Therefore, it appears that enrichment of H4K20me1 on the X chromosomes results in a reduction of H4K16ac levels on the X (Vielle et al. 2012; Wells et al. 2012). It is not clear whether H4K20me1 exerts all of its effect on transcription through H4K16ac. In C. elegans as well as other organisms, H4K20me1 is greatly increased on chromosomes during mitosis, and human condensin II binding to chromosomes is mediated in part by H4K20me1 (Liu et al. 2010). It is possible that enrichment of H4K20me1 on the C. elegans X chromosomes has a mechanistic connection to condensed chromosome structure.
The DCC may function to restrict access of RNA polymerase or transcription factors to promoter regions, impede progression of RNA polymerase through transcription units, or slow reinitiation of transcription at each gene. These possibilities are consistent with the finding that loss of DCC function leads to increased RNA polymerase II on the X chromosome (Pferdehirt et al. 2011). Given the similarity of the DCC to the 13S condensin I complex, a likely mechanism for the down-regulation of gene expression is DCC-mediated condensation of chromatin. It is not known, however, whether the X chromosome is more condensed compared to the autosomes. X-chromosome promoters have higher nucleosome occupancy than autosomal promoters, but this higher nucleosome occupancy is not dependent on the DCC and is likely due to the higher GC content of X-linked promoters (Ercan et al. 2011). Future studies are required to dissect the functional connection between the DCC, H4K20 methylation, X-chromosome compaction, nucleosome organization, and transcription.
Clues about the mechanism of repression may also be found at her-1, the only autosomal target at which the DCC is known to function, and which displays 20-fold DCC-mediated down-regulation of gene expression (Fig. 5A) (Dawes et al. 1999; Chu et al. 2002). Repression of her-1 promotes hermaphrodite sexual development (Fig. 2). An interesting question is how the DCC achieves 10-fold greater repression at her-1 than it achieves on the X chromosome. A few differences between X-chromosome-associated DCC and her-1-associated DCC have been noted. First, although the DCC is recruited to the X chromosomes by SDC-2, the DCC is recruited to her-1 by SDC-3 (Dawes et al. 1999; Yonker et al. 2003). Second, a different sequence motif is responsible for recruitment of the DCC to her-1 than to the Xs (Chu et al. 2002). Third, DPY-21 is present on the X chromosomes, but not at the her-1 locus (Yonker and Meyer 2003). DPY-21 is a conserved protein with a proline-rich amino terminus, but comparisons to other proteins do not reveal an apparent function. It could be that DPY-21 modulates the function of the DCC to weakly repress transcription of many genes on the X, whereas the DCC without DPY-21 strongly represses transcription at the her-1 locus. Dissecting how the DCC at her-1 functions differently from the DCC localized to X may reveal important aspects of DCC mechanism.
6. COMPENSATORY UP-REGULATION OF X-LINKED GENES
Somatic down-regulation of the X chromosomes by the DCC compensates for the X-chromosome dosage difference between males and females. A second dosage compensation mechanism is thought to equalize overall transcript levels between X and autosomes. In animals with X chromosomes, cells in males contain a single X chromosome compared to two copies of each autosome (i.e., XY or XO, AA). This causes a potential haploinsufficiency for X-linked genes in males that is independent of the X-chromosome dosage imbalance between sexes. Susumu Ohno first hypothesized that during the evolution of X chromosomes, transcription of X-linked genes was doubled from the single X to match the transcript output from a diploid complement of autosomes; dosage compensation in females evolved to repress the inappropriate increase in X transcription in XX animals (Ohno 1967). This combination of up- and down-regulation effectively creates a diploid dose of X transcripts in both sexes (Fig. 7). Although one study claimed that compensatory up-regulation of X-linked genes does not occur in C. elegans (Xiong et al. 2010), subsequent studies that took into account the proliferation of germ cells during development showed that X up-regulation does occur in somatic cells (Deng et al. 2011; Kharchenko et al. 2011b). The clearest demonstration of this phenomenon was a microarray experiment showing that the mean and median X:A expression ratio in XO animals was 0.98, very close to the ratio of ~1 that occurs in XX animals, indicating that X-linked genes are up-regulated in XO animals (Deng et al. 2011). Thus, up-regulation of X-linked genes in both sexes requires a compensating mechanism that specifically down-regulates X-linked genes in animals with two X chromosomes. The molecular mechanism by which transcriptional up-regulation occurs on the X and how it is restricted to the X in both sexes are not known and are important areas for future investigation.
7. GERMLINE DEVELOPMENT AND GLOBAL REPRESSION OF THE X CHROMOSOMES
In C. elegans, the somatic mode of X-chromosome regulation by the DCC is inoperative in germ cells. Early evidence for this was the observation that some DCC components are not expressed in germ cells (e.g., SDC-2, DPY-27) and other DCC components are expressed in germ cells but are localized to all chromosomes (e.g., MIX-1, DPY-26, and DPY-28). MIX-1, DPY-26, and DPY-28 are, in fact, components of canonical condensin I in C. elegans (Fig. 4). In the germline, those DCC proteins are engaged in more general roles in mitotic and meiotic chromosome organization and segregation.
The absence of DCC members in the germline raises the question of whether any mode of dosage compensation occurs in this tissue. Recall that one function of dosage compensation is to achieve equivalent expression of X-linked genes between the sexes for viability and normal development. Current evidence suggests that in contrast to the twofold down-regulation of both X chromosomes in XX somatic cells, the X chromosomes are globally repressed during most stages of germline development in both XX and XO animals (Fig. 3). The specific mechanisms that regulate the X chromosomes in germ cells bear little resemblance in either form or function to the somatic mechanisms already described in this article.
The adult gonads of both sexes in C. elegans contain an orderly progression of germ cell stages. Germ cells proliferate in the distal region, enter meiosis in the middle region, and complete gametogenesis in the proximal region (Figs. 1 and and8)8) (reviewed in Schedl 1997). In XO males, this progression occurs in a single tubular testis that continuously produces sperm. In XX hermaphrodites, two tubular gonad arms initially produce sperm during a late larval stage and then switch to the production of oocytes in adulthood. Mature oocytes are pushed into the spermathecae and are fertilized by sperm residing there before further extrusion into the uterus. The production of some sperm for a limited time in development by XX worms thus allows the “hermaphroditic” mode of reproduction in the adult. However, the ovary and certain other somatic tissues in adult XX animals can be considered female in identity and function.
The X chromosomes in the germline are initially transcriptionally repressed both in XX hermaphrodites and in XO males. The evidence for X repression comes from immunofluorescence analysis and genome-wide transcript profiling. Immunostaining of germlines revealed that the X chromosomes have higher levels of repressive histone modifications (H3K27 methylation and H3K9 methylation) than the autosomes (Fig. 8) (Kelly et al. 2002; Bender et al. 2004). The X chromosomes also lack several marks of actively expressed chromatin: H4 acetylation on K8, K12, and K16, H3K4 methylation, and the H3 variant H3.3 (Kelly et al. 2002; Ooi et al. 2006; Arico et al. 2011). Marks of active chromatin are absent from the X chromosomes throughout all stages of germline development in XO males. In XX hermaphrodites, such marks are absent from the X chromosomes in proliferating and early meiotic germ cells, but appear on the Xs during oogenesis (Kelly et al. 2002). These findings suggested that the X chromosomes are transcriptionally silent during all stages of germ cell development except oogenesis.
Genome-wide transcript profiling performed in worms that contain or lack germ cells showed that there is a striking asymmetry in the location of genes with germline-enriched expression; genes expressed in both the male and hermaphroditic germline, including those with enriched expression during spermatogenesis, are severely underrepresented on the X chromosome (Reinke et al. 2000; Reinke et al. 2004). Genes with enriched expression in oogenic germlines are also underrepresented on the X, but not to the same degree. Consequently, most of the genes that are required for the viability and function of germ cells are located on the autosomes. Most of the oogenesis-associated genes that reside on the X chromosome are expressed late in meiosis, which correlates with the accumulation of active histone modifications on the X chromosomes during oogenesis (Fig. 8). Thus, the bias against X-linkage is most stringent for genes that are common to both sexes and that function in the early stages of germ cell maturation. Consistent with this, primordial germ cells isolated from embryos express fewer genes from their X chromosomes than somatic cells at the same developmental stage, similar to the bias observed in adults (Spencer et al. 2011). Thus, preferential expression of autosomal genes is a feature of germ cells at all stages.
Recent transcript profiling from dissected adult hermaphrodite germlines has refined these results and revealed that the X is not as “silent” as previously thought (Wang et al. 2009; Tabuchi et al. 2011; Gaydos et al. 2012). Interestingly, genes that are transcribed in both soma and germline are observed to have significantly lower transcript levels in the germline relative to somatic tissues (Wang et al. 2009). It has been speculated that the X-linked transcripts detected in dissected full-length germlines come from oogenic germ cells, in which the X chromosomes acquire marks of active chromatin, as discussed in the preceding paragraphs. However, two observations instead suggest that there is some transcription from the X in germ cells at all stages and argue against oogenic germ cells being the sole source of X transcripts. First, isolated primordial germ cells express some X-linked genes (Spencer et al. 2011). Second, adult germlines that were dissected to include proliferating and early meiotic germ cells, but not oogenic germ cells, transcribe ~15% of the genes on the X (Tabuchi et al. 2011).
In summary, in the C. elegans germline there is chromosome-wide and significant dampening of transcription from the X. As a consequence, germline development relies predominantly on expression of genes located on the autosomes. The X chromosome does house its fair share of “housekeeping genes” that are expressed in all cells, but they are expressed at lower levels in germ cells than in somatic cells. The predominant reliance of C. elegans germ cells on autosomal genes raises the question of how germline-expressed genes became preferentially located on the autosomes. Interestingly, a number of gene duplications with X/autosome paralogs have been identified in which the autosomal copy is uniquely required for germ cell function and the X-linked copy functions in somatic lineages (Maciejowski et al. 2005). Gene duplication followed by germline dependence on the autosomal copy offers a potential mechanism for exclusion of essential germline genes from the inhospitable environment of the X chromosome. Genes that are only required during late oogenesis (i.e., only required in late stage female germ cells) were likely not subject to the selective pressures that excluded early germline-required genes from the X chromosome. The selective pressures likely included the evolved absence of a pairing partner for the X in male meiosis, as discussed in Section 8. Similar forces appear to be acting in other species including fruit flies and mammals (Wu and Xu 2003).
8. MEIOTIC SILENCING OF THE SINGLE X IN MALES
The earliest suggestion that the X chromosome differs from the autosomes in the germline came from cytological observations. The single X in male worms hypercondenses during pachytene in meiotic prophase, forming a ball-like structure reminiscent of the XY “sex body” seen during male meiosis in mammals (Fig. 8) (Goldstein and Slaton 1982; Handel 2004). The autosomes condense later in meiotic prophase near the onset of spermatogenesis. Premature X condensation is also seen during sperm meiosis in XX hermaphrodites and in sexually transformed XX males, suggesting that premature X condensation is in response to germ cell sex and not to X-chromosome ploidy or pairing status. Accordingly, in XX hermaphrodites, germ cells destined for oogenesis do not show premature X condensation.
In addition to premature condensation, a separate mechanism that depends on unpaired DNA in meiosis causes the single X chromosome in XO males to transiently accumulate a striking enrichment of H3K9me2, which appears during pachytene and disappears by diakinesis (Kelly et al. 2002; Bessler et al. 2010) (Fig. 8). This X enrichment of H3K9me2 does not occur during spermatogenesis in either XX hermaphrodites or sexually transformed XX males, but does occur during pachytene in sexually transformed XO hermaphrodites and in XX animals in which the X chromosomes do not pair (e.g., him-8 mutants; Bean et al. 2004; Bessler et al. 2010). The specific acquisition of a heterochromatin mark on the X in XO meiosis thus appears to be a consequence of its unpaired status, and not the sex of the germline through which it is passing. Targeting of H3K9me2 to unpaired DNA is not limited to X-chromosome sequences; it is also found on unpaired autosomal fragments and translocations (Bean et al. 2004). H3K9me2 on unpaired X chromosomes is generated by the SETDB1 homolog MET-2 and its pattern is regulated by the chromatin protein HIM-17 (Reddy and Villeneuve 2004; Bessler et al. 2010). The finding that met-2 mutant males do not display defects in transmission of X chromosomes during meiosis suggests that concentrating H3K9me2 on the X is not essential for proper meiotic chromosome segregation. Whether loss of H3K9me2 affects X silencing in males, however, has not yet been assessed.
Targeted repression of unpaired DNA in meiosis is not unique to C. elegans. Similar recognition and repression of unpaired DNA occurs in other organisms during meiosis, including Neurospora and mice. This is referred to as MSUC (meiotic silencing of unsynapsed chromatin; also referred to as MSUD, for meiotic silencing of unpaired DNA; Shiu et al. 2001; Baarends et al. 2005; Turner 2005; Kelly and Aramayo 2007). In mouse, for example, the poorly synapsed XY “sex body” is similarly enriched in H3K9me2 during male meiosis, and this is a consequence of its unsynapsed status (Cowell et al. 2002; Turner et al. 2005). Meiotic silencing in Neurospora requires the activity of proteins with conserved roles in RNA interference (see Aramayo and Selker 2013). These include an RNA-dependent RNA polymerase (RdRP), an Argonaute-related protein (a conserved component of RNA-induced silencing complexes), and the Dicer nuclease (reviewed in Kelly and Aramayo 2007; see Martienssen and Moazed 2014). In C. elegans, the enrichment of H3K9me2 on unpaired DNA requires the RdRP EGO-1 and the Argonaute protein CSR-1, but does not require Dicer (Maine et al. 2005; She et al. 2009). This suggests that although there is conservation of meiotic silencing (repression of unpaired DNA), the mechanism by which this is achieved likely evolved differently in different organisms.
In contrast to what happens in XO male meiosis, the X chromosomes in either XX spermatogonia or XX oogonia are not enriched in H3K9me2. This difference is likely because of the complete synapsis of the Xs in hermaphrodite meiosis. Why would silencing of unpaired DNA be a conserved feature of sexual reproduction? In many organisms, homolog pairing is unique to meiosis, and during synapsis novel insertions unique to one homolog would be exposed as regions of unpaired DNA. It has been proposed that recognition and silencing of unpaired sequences during meiosis provides a mechanism for self-scanning of a diploid genome, and could provide protection against invasion by, or expansion of, transposable elements. This protection would be needed only in the germline because somatic transposon insertions or expansions are not passed to the next generation. As a consequence, genes required during meiosis would encounter a strong selection against residence on an unpaired chromosome (such as the male X). Such selection may have led to the unique genetic profile of the X that is observed in C. elegans, as discussed in Section 7. It is interesting to speculate that the genomic warfare between transposons and their hosts, and the silencing mechanisms that have evolved as weapons in this battle, have shaped genomes and led to some of the X-autosome differences discussed in Section 7.
9. REGULATION OF X-CHROMOSOME REPRESSION BY THE MES HISTONE MODIFIERS
Section 8 describes repression via heterochromatin formation that is specific to the single X in XO males and restricted to the pachytene stage of meiosis due to MSUC. How are the X chromosomes maintained in a repressed chromatin state during other stages of male germline development and in the germlines of XX hermaphrodites? Genetic screens for maternal-effect sterile (mes) mutants identified a set of four mes genes that participate in X-chromosome repression in XX animals and likely in XO animals as well. A combination of genetic and molecular analyses have shown that the encoded MES proteins effect repression through regulating part of the spectrum of histone modifications found on the X chromosomes in germ cells. Their functions are essential for the survival and development of germ cells.
The MES proteins generate two opposing modifications on the tail of histone H3: methylation of H3K27, which is associated with gene repression, and methylation of H3K36, which is associated with active gene expression. Methylation of H3K27 is catalyzed by MES-2 in association with MES-3 and MES-6 (Fig. 9A). This trimeric complex resembles the Polycomb repressive complex PRC2 in fruit flies and vertebrates (Xu et al. 2001; Bender et al. 2004; Ketel et al. 2005; see Grossniklaus and Paro 2014). MES-2 and MES-6 are the worm orthologs of two PRC2 subunits, E(Z) (enhancer of zeste) and ESC (extra sex combs; Table 1); MES-3 is a novel protein. MES-2’s SET domain is responsible for its histone lysine methyltransferase (HKMT) activity, whereas MES-6 and MES-3 appear to be required either for substrate binding or to boost catalytic activity (Ketel et al. 2005).
MES-2, MES-3, and MES-6 are responsible for all detectable H3K27me2 and H3K27me3 in the germline and in early embryos, but another as-yet undiscovered HKMT contributes to H3K27 methylation in the primordial germ cells and in larval and adult somatic tissues. Importantly, within the germline H3K27me3 is enriched on the X chromosomes (Fig. 8) (Bender et al. 2004). Accordingly, one consequence of abolishing H3K27 methylation in the germline is activation of genes on the X. In progeny of mes-2, mes-3, or mes-6 mutant mothers, the X chromosomes in the germline lack H3K27me2/3, acquire marks of active chromatin (e.g., H3K4me and H4K12ac), and become decorated with the transcriptionally active form of RNA polymerase II (Fong et al. 2002; Bender et al. 2004). These findings suggest that the MES-2/3/6 complex participates, perhaps directly, in repressing the X chromosomes in the germline of worms. Indeed, derepression of the two Xs is proposed to be the cause of germline degeneration observed in XX progeny of mes mutant mothers because XO progeny of those same mothers can be fertile, perhaps because derepression of a single X is tolerated during germline development, or more likely because another mechanism, such as heterochromatinization of the single X through MSUC, maintains repression in the XO germline (Garvin et al. 1998). It is interesting to note that, similar to the involvement of MES-2 and MES-6 in germline X repression in C. elegans, the vertebrate homologs of MES-2 and MES-6 are involved in somatic X inactivation in XX mammals (see Brockdorff and Turner 2014; Grossniklaus and Paro 2014).
The fourth MES protein involved in X repression in the germline is MES-4. Its distribution by immunostaining is novel among chromosome-associated proteins and exactly opposite to what might be expected. In contrast to the other MES proteins, MES-4 associates with the five autosomes in a banded pattern and is strikingly absent from most of the length of the X chromosome (Fig. 9B) (Fong et al. 2002). MES-4, like MES-2, contains a SET domain and also has HKMT activity (Bender et al. 2006). It is responsible for H3K36me2 and contributes to H3K36me3 in the germline and embryos. As predicted by the autosomal concentration of MES-4, H3K36 methylation is also dramatically concentrated on the autosomes. Recent analysis of the distributions of MES-4, H3K36 methyl marks, and RNA polymerase II by chromatin immunoprecipitation in embryos provided insights into how MES-4 is targeted to the autosomes and what role it serves there (Furuhashi et al. 2010; Rechtsteiner et al. 2010). In embryos, MES-4 and H3K36me2/3 reside in the body of genes that share the property of having been expressed in the maternal germline. Those genes include ubiquitously expressed genes, and germline-specific genes that were expressed in the maternal germline but are not expressed during embryogenesis and thus lack RNA polymerase II in embryos. The latter category revealed that MES-4 can associate with genes independently of RNA polymerase II, which distinguishes it from other H3K36 HKMTs. The picture that has emerged is that MES-4 is a maintenance HKMT whose function is to propagate the memory of germline gene expression from the parental germline to the germline in progeny (Fig. 9C). Thus, MES-4 serves a truly epigenetic role, by transmitting a chromatin mark (H3K36me) across generations. This function is critical for germ cell survival. The concentration of MES-4 on the autosomes is likely explained by MES-4’s association with germline-expressed genes, which are concentrated on the autosomes and nearly absent from the X, as discussed in Section 7.
MES-4’s participation in repressing the X chromosome emerged from transcript profiling of germlines dissected from fertile mes-4 mutant mothers (Bender et al. 2006; Gaydos et al. 2012). The primary change in gene expression was up-regulation of genes on the X. How does MES-4, which is concentrated on the autosomes, participate in repressing genes on the X? The current model is that MES-4-mediated H3K36 methylation of germline-expressed genes on the autosomes repels MES-2/3/6 from those genes and helps concentrate its repressive activity on other regions of the genome, including the X chromosomes (Fig. 9A). The main evidence for this model is the finding that loss of MES-4 from germline genes causes H3K27me3 to spread to germline genes and results in reduced H3K27me3 on the X chromosome (Gaydos et al. 2012). In fact, in genome-wide chromatin immunoprecipitation studies in diverse species, H3K36me3 and H3K27me3 generally occupy nonoverlapping regions of the genome, consistent with those marks excluding each other and defining distinct genomic regions (Kharchenko et al. 2011a; Liu et al. 2011; Gaydos et al. 2012). Furthermore, the notion that H3K36 methylation antagonizes H3K27 methylation is supported by the finding that prior methylation of H3K36 prevents methylation of K27 on the same histone tails in vitro (Schmitges et al. 2011; Yuan et al. 2011). The model presented for MES-4 participation in X repression in worms (Fig. 9A) is similar to the model for Dot1 participation in telomeric silencing in Saccharomyces cerevisiae (van Leeuwen and Gottschling 2002). Dot1-mediated methylation of H3K79 along chromosomes is thought to repel the Sir repressors and help focus their action on the telomeres. Loss of Dot1 allows spreading of the Sirs from telomeres and results in telomeric desilencing. MES-4 and Dot1 illustrate how histone modifiers can contribute to proper distributions of repressors by antagonizing promiscuous repressor binding (van Leeuwen and Gottschling 2002).
The MES proteins function epigenetically in two intertwined but conceptually distinct manners: regulation of histone modifications and chromatin states, as described in the preceding paragraphs, and maternal-effect regulation. A maternal-effect mutation is defined as one whose mutant phenotype is not revealed in first-generation homozygous mutants, but instead shows up in their progeny. In the case of first-generation mes/mes mutants, the presence of some wild-type MES product produced by the mes/+ mother and packaged into the oocyte is sufficient for the proper expansion of the two primordial germ cells into over a thousand functional germ cells in adults. The germ cells in these fertile mes/mes worms, however, cannot produce functional MES product for their offspring. As a result, in these offspring, the primordial germ cells undergo little proliferation and degenerate. The HKMT activities encoded by mes-2 and mes-4 must establish a heritable chromatin state that is properly maintained in the many descendants of the two initial primordial germ cells. MES-2, MES-3, and MES-6 operate in a complex to concentrate a repressive chromatin modification (H3K27me3) on the X chromosomes in the germline, and participate, probably directly, in X repression. MES-4 participates in X repression from a distance by methylating H3K36 on germline-expressed genes on the autosomes, which repels and helps focus the activity of the MES-2/3/6 complex and H3K27me3 on the X. The MES system is thought to act epigenetically in the mother’s germline and in early embryos to establish chromatin domains that are properly marked for subsequent expression (autosomal regions) or repression (the X chromosomes) during germline development in larvae (see Fig. 9A,C). Loss of the MES system leads to germline death and sterility, likely due, at least in part, to derepression of the X chromosomes.
The discussion thus far has focused on factors and mechanisms involved in repressing expression of X-linked genes in the germline. Intriguingly, several members of the C. elegans DRM complex appear to be involved in promoting what little expression of X-linked genes does occur in the germline. The DRM complex includes the worm homologs of Retinoblastoma, E2F, DP, and LIN-54/Mip120. The complex is named for DP, Retinoblastoma, and Myb-MuvB and is related to the mammalian DREAM complex. Loss of any of the C. elegans DRM proteins causes genes on the X to be down-regulated in the germline (Tabuchi et al. 2011). Like MES-4, DRM components appear, by immunostaining, to be concentrated on the autosomes in germ cells, leading to the model that like MES-4, DRM indirectly regulates transcription of genes on the X. An interesting possibility is that MES-4 and DRM antagonistically influence transcription of germline-expressed genes on the autosomes, and as a result have opposite effects on transcription of genes on the X (Tabuchi et al. 2011).
10. PATERNAL X INACTIVATION IN EARLY EMBRYOS
The genomes contributed by the different gametes arrive in the zygote with vastly different epigenetic histories (Figs. 8 and and10).10). Although the X chromosome is inactive in early germ cell stages in both sexes (e.g., Fig. 10—nascent germline and mitosis stages), the X becomes transcriptionally active during the late pachytene stage of oogenesis (e.g., Figs. 8 and and10—oogenesis)10—oogenesis) (Fong et al. 2002; Kelly et al. 2002). In contrast, during spermatogenesis in both hermaphrodites and males the X is never activated (e.g., Figs. 8 and and10—spermatogenesis),10—spermatogenesis), undergoes premature condensation, and in XO meiosis is additionally enriched in H3K9me2 (Fig. 8) (Kelly et al. 2002; Bean et al. 2004). During sperm formation, although some canonical histones are replaced by specialized, sperm-specific histone variants and protamine-like basic proteins (Chu et al. 2006), the sperm genome possesses and enters the egg with easily detectable levels of histone H3 and several histone modifications, including H3K4me2, on the autosomes (Arico et al. 2011). The oocyte chromatin also continues to show significant levels of most activating histone modifications even during chromosome condensation in diakinesis (Fig. 8). RNA polymerase II levels associated with DNA drop precipitously in diakinesis-stage oocytes, suggesting that the histone modifications retained by the chromatin reflect recent transcriptional history instead of ongoing transcriptional activity (Kelly et al. 2002). Thus, the zygote inherits two epigenetically different genomes and, in particular, two X chromosomes with very different transcriptional histories—a recently active, oocyte-derived Xm and a sperm-derived Xp with little or no recent transcriptional activity.
After entry into the oocyte, the sperm DNA displays histone modifications such as H3K4me2 (Arico et al. 2011) as it begins to decondense to form the sperm pronucleus. In striking contrast to the autosomes, the decondensing Xp lacks H3K4me2 and histone H3 acetylation (Bean et al. 2004). There is, however, no difference in histone H4 modifications between the Xp and the autosomes. In the oocyte pronucleus, all chromosomes, including the Xm, are similarly modified and remain so throughout embryogenesis. Intriguingly, the Xp-specific absence of H3 modifications is maintained after DNA replication and survives multiple rounds of DNA replication and cell division, and thus has been termed an “epigenetic imprint.” However, the imprint is gradually lost; that is, H3-specific modifications become increasingly detectable on the Xp until there are no obvious differences in H3K4me2 levels between the Xp and other chromosomes. An attractive scenario is that the absence of H3K4me2 and other marks of active chromatin from the Xp in early embryos reflects the transcriptionally silent state of the Xp during spermatogenesis (Figs. 8 and and10),10), and the Xp acquires marks of active chromatin as transcription from the zygotic genome is activated. It is noteworthy that maternally supplied H3.3, an H3 variant associated with active gene expression, exchanges onto the Xp, Xm, and the autosomes upon fertilization, yet it fails to acquire active histone modifications specifically on Xp (Ooi et al. 2006; Arico et al. 2011).
The Xp imprint in XX embryos is detected in both cross-progeny (from XO-derived sperm) and self-progeny (from XX-derived sperm). The pairing status of the X chromosome during spermatogenesis, and thus H3K9me2 targeting and enrichment on the X, therefore does not play an obvious role in establishment of the Xp imprint. However, the stability of the imprint—that is, the number of cell divisions after which it can still be readily observed—is significantly increased in offspring from XO-derived sperm relative to XX-derived sperm (Bean et al. 2004). Therefore, heterochromatin assembly on unpaired DNA during meiosis has effects that persist through early embryonic stages. Importantly, both pairing-based meiotic silencing and imprinted Xp inactivation are also observed in mammals, as discussed in Brockdorff and Turner (2014).
Genetic imprinting (covered in detail in Barlow and Bartolomei 2014) has long been thought to be absent in C. elegans, as animals with uniparental inheritance of any single chromosome are viable and fertile (Hodgkin et al. 1979; Haack and Hodgkin 1991). In particular, there are no reported deleterious consequences of patriclinous inheritance of the X (i.e., XpXp animals). The unique genetic composition of the X chromosome, however, may help to explain why uniparental inheritance is not detrimental in C. elegans. In addition to a paucity of germline-expressed loci on the X chromosome, genes encoding early zygotic transcripts and those required for early embryonic development are also strikingly underrepresented on the X (Piano et al. 2000; Baugh et al. 2003). Thus, most genes whose products are essential for the very early stages during which the Xp is inactive are unlikely to reside on the X, rendering X-specific uniparental inheritance inconsequential in genetic tests.
Xp inactivation does, however, suggest a reason why somatic dosage compensation is not fully active in early embryos. The assembly of DCC components on the X chromosomes in XX embryos is not detectable by antibody staining until approximately the 30-cell stage. This is shortly after the Xp becomes fully decorated with H3 modifications, and is thus presumably fully activated. Activation of somatic dosage compensation is responsive to levels of the XSEs, the X-linked products that comprise the X portion of the X:A ratio, as discussed in Section 2. Full or partial repression of these elements on the Xp may render the early embryo functionally XO (i.e., the X:A is interpreted as 0.5). As the Xp reactivates with increased rounds of cell division, the level of X transcription may finally reach the critical threshold at which a two X-chromosome dosage is sensed and X:A equals 1, triggering the dosage compensation cascade. One might consider this a switch from maternal/paternal control of dosage compensation to zygotic control.
11. CONCLUDING REMARKS
C. elegans is one among many animals that uses a chromosome-based mechanism of sex determination in which the two sexes have a different number of X chromosomes. Interestingly, the germline and soma in worms have evolved distinct mechanisms to deal with this difference in X ploidy. In the somatic tissues, a conserved complex that is normally used for chromatin condensation and segregation during mitosis and meiosis appears to have been co-opted and adapted to achieve twofold repression of both X chromosomes in XX animals. This complex is recruited to the X chromosome in part by specific DNA sequences, and spreads along the X via a sequence-independent mechanism. Although it is conceptually attractive to envisage that an “inefficient” condensin complex might serve to decrease transcriptional efficiency, whether the complex acts locally at the level of individual genes, or at a distance across the entire X, and how repression is limited to twofold are currently not understood. This somatic dosage compensation mechanism appears to have been superimposed on a separate genome-wide dosage balancing process that compensates for X aneuploidy by up-regulating all expressed X-linked genes in both sexes by a factor of 2. The mechanism by which this second process operates is not understood.
In the germline, the X chromosomes are globally repressed during early stages of germ cell development in XX animals and during all stages of germ cell development in XO animals. Silencing of the single X chromosome in males, a mechanism to protect the integrity of unpaired chromosomal segments, likely created strong evolutionary pressure to move genes required for germ cell maturation off of the X chromosome, and also to repress the two X chromosomes in hermaphrodites. Global X-chromosome repression in the germline of XO and XX animals, in fact, is also one mechanism to compensate for the X-dosage difference between the sexes. If some X-linked genes that operate in both sexes escape repression, then the question arises as to whether the germline equalizes their expression in XX versus XO animals. The answer to this is not known. Equalization in the germline would involve a mechanism other than the DCC that operates in somatic tissues.
The germline and soma differ in many fundamental ways. This article highlights the different mechanisms of X-chromosome regulation in the germline and soma. One interesting theme that has emerged is co-option of different preexisting mechanisms, including utilization of a condensin-related complex to subtly down-regulate X expression in the soma, and utilization of a PRC2-related complex to repress the Xs in the germline. The heterochromatinization of the single X in males is thought to have dramatically altered the representation of genes on the X, such that genes required for general germline functions and early embryonic development are significantly underrepresented on this chromosome. The X chromosome and its regulation in C. elegans provide a window into chromosome-wide gene regulation mechanisms and genome evolution.
Footnotes
Editors: C. David Allis, Marie-Laure Caparros, Thomas Jenuwein, and Danny Reinberg
Additional Perspectives on Epigenetics available at www.cshperspectives.org
REFERENCES
*Reference is also in this collection.
WWW RESOURCE
- http://www.wormbook.org/chapters/www_dosagecomp/dosagecomp.html Meyer BJ 2005. X-chromosome dosage compensation. In WormBook. [Abstract]
Articles from Cold Spring Harbor Perspectives in Biology are provided here courtesy of Cold Spring Harbor Laboratory Press
Full text links
Read article at publisher's site: https://doi.org/10.1101/cshperspect.a018366
Read article for free, from open access legal sources, via Unpaywall: http://cshperspectives.cshlp.org/content/6/3/a018366.full.pdf
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1101/cshperspect.a018366
Article citations
High-resolution reconstruction of a <i>C. elegans</i> ribosome sheds light on evolutionary dynamics and tissue specificity.
RNA, 30(11):1513-1528, 16 Oct 2024
Cited by: 0 articles | PMID: 39209556
Single-nucleus atlas of the Artemia female reproductive system suggests germline repression of the Z chromosome.
PLoS Genet, 20(8):e1011376, 30 Aug 2024
Cited by: 0 articles | PMID: 39213449 | PMCID: PMC11392275
XIST dampens X chromosome activity in a SPEN-dependent manner during early human development.
Nat Struct Mol Biol, 31(10):1589-1600, 04 Jun 2024
Cited by: 3 articles | PMID: 38834912 | PMCID: PMC11479943
Characterization of the Pristionchus pacificus "epigenetic toolkit" reveals the evolutionary loss of the histone methyltransferase complex PRC2.
Genetics, 227(1):iyae041, 01 May 2024
Cited by: 0 articles | PMID: 38513719 | PMCID: PMC11075575
Comparative Genomics of Sex, Chromosomes, and Sex Chromosomes in Caenorhabditis elegans and Other Nematodes.
Methods Mol Biol, 2802:455-472, 01 Jan 2024
Cited by: 0 articles | PMID: 38819568
Review
Go to all (37) article citations
Other citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Restricting dosage compensation complex binding to the X chromosomes by H2A.Z/HTZ-1.
PLoS Genet, 5(10):e1000699, 23 Oct 2009
Cited by: 24 articles | PMID: 19851459 | PMCID: PMC2760203
Untangling the Contributions of Sex-Specific Gene Regulation and X-Chromosome Dosage to Sex-Biased Gene Expression in Caenorhabditis elegans.
Genetics, 204(1):355-369, 29 Jun 2016
Cited by: 8 articles | PMID: 27356611 | PMCID: PMC5012400
A molecular link between gene-specific and chromosome-wide transcriptional repression.
Genes Dev, 16(7):796-805, 01 Apr 2002
Cited by: 53 articles | PMID: 11937488 | PMCID: PMC186330
X-Chromosome dosage compensation.
WormBook, 1-14, 25 Jun 2005
Cited by: 46 articles | PMID: 18050416
Review
Funding
Funders who supported this work.
NCI NIH HHS (1)
Grant ID: T32 CA009156
NIGMS NIH HHS (2)
Grant ID: R01 GM107293
Grant ID: R01 GM034059